Cefaloglycin
Cat. No.：YN250659
CAS No. ：3577-01-3
| 产品名称: | Cefaloglycin |
| CAS No.: | 3577-01-3 |
| Chemical Name: | [6R-[6α,7β(R*)]]-3-[(Acetyloxy)methyl]-7-[(aminophenylacetyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; [(6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2R)-aminophenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; |
| Synonyms: | Cephaloglycin |
| 分子量: | 405.42 |
| 分子式: | C₁₈H₁₉N₃O₆S |
| SMILES: | OC(C(N(C1=O)[C@@](SC2)([H])[C@@H]1NC([C@@H](C3=CC=CC=C3)N)=O)=C2COC(C)=O)=O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Cefaloglycin (Cephaloglycin) 是一种具有口服活性的肾毒性 β-内酰胺类 (β-lactam) 头孢菌素抗生素，具有抗菌活性。Cefaloglycin 对肠球菌以外的革兰氏阳性球菌 (Gram-Positive cocci) 有活性。Cefaloglycin 对线粒体底物的摄取和呼吸也具有毒性。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Yoshimura, F., et al.: Antimicrobial Agents Chemother., 27, 84 (1985)
Daniel, H., et al.: J. Cin. Invest., 92, 2215 (1993)
